Peer review reports
From: Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV
Original Submission |
2 Feb 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
31 Mar 2021 |
Reviewed |
Reviewer Report
|
1 Jun 2021 |
Reviewed |
Reviewer Report
|
15 Jun 2021 |
Author responded |
Author comments - Gilles Darcis
|
Resubmission - Version 4 |
15 Jun 2021 |
Submitted |
Manuscript version 4
|
1 Jul 2021 |
Author responded |
Author comments - Gilles Darcis
|
Resubmission - Version 5 |
1 Jul 2021 |
Submitted |
Manuscript version 5
|
Publishing |
19 Jul 2021 |
Editorially accepted |
|
6 Sep 2021 |
Article published |
10.1186/s12879-021-06479-9
|
Learn about peer review